Autosensitization in Malignant Neoplasms
DOI:
https://doi.org/10.37482/2687-1491-Z159Keywords:
autosensitization, malignant neoplasms, human immune system, immune response, IL-10, antiphospholipid antibodies, anti-DNA and anti-RNA antibodies, TNF-αAbstract
Autoantibody formation, as a physiological mechanism of homeostatic regulation, leads to pathological processes when overexpressed. Autoantibodies are produced when the concentration of autoantigens increases, which occurs as a result of tumour necrotization and metastasizing. Autosensitization in known to develop in chronic inflammatory and tumour processes. It is of interest to clarify the significance of antiinflammatory cytokines for the formation of autoantibodies in malignant neoplasms. The purpose of this article was to identify the link between autoantibody formation and concentrations of anti-inflammatory cytokines in cancer patients. Materials and methods. Immunoassay data of 210 cancer patients of Biokor medical company (Arkhangelsk) were analysed. In the peripheral venous blood, the following were measured: antibodies against phospholipid (IgM, IgG), thyroid peroxidase (anti-TPO) and streptolysin (anti-streptolysin O), anti-double stranded DNA (anti-dsDNA) and anti-ribonucleoprotein (anti-RNP), as well as interleukins (IL) 1β, 4, 6, 10 and 13, and tumour necrosis factor (TNF-α). Results. High frequency of elevated concentrations of anti-dsDNA, antiRNP and anti-streptolysin O in the blood of cancer patients was recorded (51.72, 40.48 and 34.78 %, respectively). Most often, increased levels of anti-dsDNA were found, their mean concentrations being the highest as well. The frequency of elevated concentrations of antiphospholipid antibodies was 11.11 % for IgM and 18.42 % for IgG. Increased anti-TPO levels were observed in 14.29 % of cases. Elevated IL-10, IL-1ß and IL-4 were found in
86.90, 23.81 and 10.81 % of cased, respectively, while IL-6 and IL-13 in 5.71 and 3.85 % of cases, respectively. Mean concentrations of the cytokines under study were within the physiological limits, except for IL-10 and TNF-α, which were increased. Elevated concentrations of autoantibodies were associated with increased blood levels of TNF-α and IL-10. Thus, abnormally high blood concentrations of IL-10, which reduces cellular receptor activity, can indirectly contribute to a decrease in the activity of autoantigen disposal and clearance and prolong autosensitization.
Downloads
References
Добродеева Л.К., Сенькова Л.В., Лютфалиева Г.Т., Корниенко Е.Б., Преловская И.Б., Добродеев Г.В. Содержание аутоантител у практически здоровых людей // Физиология человека. 2006. Т. 32, № 1. С. 99–107.
Добродеева Л.К., Суслонова Г.А. Аутоантитела у практически здоровых людей // Иммунология. 1990. № 2. С. 52–55.
Лютфалиева Г.Т., Добродеева Л.К. Аутоантитела: физиологическое значение в регуляции гомеостаза // Экология человека. 2007. № 8. С. 38–42.
Добродеева Л.К., Штаборов В.А., Меньшикова Е.А., Добродеев К.Г. Активность иммунных реакций в зависимости от характера питания и состояния органов желудочно-кишечного тракта. Екатеринбург: УрО РАН, 2018. 172 с.
Cudrici C.D., Boulougoura A., Sheikh V., Freeman A., Sortino O., Katz J.D., Sereti I., Siegel R.M. Characterization of Autoantibodies, Immunophenotype and Autoimmune Disease in a Prospective Cohort of Patients with Idiopathic CD4 Lymphocytopenia // Clin. Immunol. 2021. Vol. 224. Art. № 108664. https://doi.org/10.1016/j.clim.2021.108664
Lee A.Y.S., Reed J.H., Gordon T.P. Anti-Ro60 and Anti-Ro52/TRIM21: Two Distinct Autoantibodies in Systemic Autoimmune Diseases // J. Autoimmun. 2021. Vol. 124. Art. № 102724. https://doi.org/10.1016/j.jaut.2021.102724
Xiao Z.X., Miller J.S., Zheng S.G. An Updated Advance of Autoantibodies in Autoimmune Diseases // Autoimmun. Rev. 2021. Vol. 20, № 2. Art. № 102743. https://doi.org/10.1016/j.autrev.2020.102743
Chen D.S., Mellman I. Elements of Cancer Immunity and the Cancer–Immune Set Point // Nature. 2017. Vol. 541, № 7637. Р. 321–330. https://doi.org/10.1038/nature21349
Walker J.A., McKenzie A.N.J. T H2 Cell Development and Function // Nat. Rev. Immunol. 2018. Vol. 18, № 2. Р. 121–133. https://doi.org/10.1038/nri.2017.118
Добродеева Л.К., Патракеева В.П., Стрекаловская М.Ю. Иммунные реакции в зависимости от стадии онкологического заболевания // Якут. мед. журн. 2022. № 2(78). С. 60–63.
Davoodzadeh Gholami M., Kardar G.A., Saeedi Y., Heydari S., Garssen J., Falak R. Exhaustion of T Lymphocytes in the Tumor Microenvironment: Significance and Effective Mechanisms // Cell. Immunol. 2017. Vol. 322. Р. 1–14. https://doi.org/10.1016/j.cellimm.2017.10.002
Добродеева Л.К., Самодова А.В., Карякина О.Е. Взаимосвязи в системе иммунитета. Екатеринбург: РИО УрО РАН, 2014. 198 с.
Фоменко Ю.М., Жумакаева С.С., Жумакаева А.М., Сирота В.Б., Муравлева Л.Е. Внеклеточные нуклеиновые кислоты при онкологической патологии // Соврем. проблемы науки и образования. 2018. № 2. URL: https://science-education.ru/ru/article/view?id=27547 (дата обращения: 12.05.2023).
Зибиров Р.Ф., Мозеров С.А. Характеристика клеточного микроокружения опухоли // Онкология. Журн. им. П.А. Герцена. 2018. Т. 7, № 2. С. 67–72. https://doi.org/10.17116/onkolog20187267-72
Лыжко Н.А. Молекулярно-генетические механизмы инициации, промоции и прогрессии опухолей // Рос. биотерапевт. журн. 2017. Т. 16, № 4. С. 7–17. https://doi.org/10.17650/1726-9784-2017-16-4-7-17
Bellamri N., Viel R., Morzadec C., Lecureur V., Joannes A., de Latour B., Llamas-Gutierrez F., Wollin L., Jouneau S., Vernhet L. TNF-α and IL-10, Control CXCL13 Expression in Human Macrophages // J. Jmmunоl. 2020. Vol. 204, № 9. P. 2492–2502. https://doi.org/10.4049/jimmunol.1900790
Rasquinha M.T., Sur M., Lasrado N., Reddy J. IL-10 as a Th2 Cytokine: Differences Between Mice and Humans // J. Jmmunol. 2021. Vol. 207, № 9. Р. 2205–2215. https://doi.org/10.4049/jimmunol.2100565
